Marwa M Mounier

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Saccharomyces Cerevisiae

Staphylococcus Aureus

Advanced Non Small Cell Lung Cancer

Top Venues

Molecules (Basel, Switzerland)

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wael A El-Sayed, Fahad M Alminderej, Marwa M Mounier, Eman S Nossier, Sayed M Saleh, Asmaa F Kassem
Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2. Molecules (Basel, Switzerland) 27 (7) (2022)
Wael A El-Sayed, Fahad M Alminderej, Marwa M Mounier, Eman S Nossier, Sayed M Saleh, Asmaa F Kassem
New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation. Molecules (Basel, Switzerland) 27 (17) (2022)
Gaber O Moustafa, Ahmed Shalaby, Ahmed M Naglah, Marwa M Mounier, Heba El-Sayed, Manal M Anwar, Eman S Nossier
Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide-Glycyrrhetinic-Acid-Based Derivatives. Molecules (Basel, Switzerland) 26 (15) (2021)
Ahmed M Naglah, Gaber O Moustafa, Ahmed A Elhenawy, Marwa M Mounier, Heba El-Sayed, Mohamed A Al-Omar, Abdulrahman A Al-Mehizia, Mashooq Ahmad Bhat
Nα-1, 3-Benzenedicarbonyl-Bis-(Amino Acid) and Dipeptide Candidates: Synthesis, Cytotoxic, Antimicrobial and Molecular Docking Investigation. Drug design, development and therapy 15 (2021)